Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 6321–6340 of 17,529 recalls

October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 23, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Alprazolam Tablets

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Distributed by: Chattem

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Maximum Strength Zantac 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
October 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 75 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund